SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Aptose Biosciences Inc. (APTO) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分： 43/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
0/100
Debt-to-Equity & liquidity
→ Health
估值概览 — APTO
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-10.41
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-16.31 |
$0.00 |
$-13.86M |
- |
| 2017 |
$-7.84 |
$0.00 |
$-11.66M |
- |
| 2018 |
$-12.97 |
$0.00 |
$-28.87M |
- |
| 2019 |
$-7.86 |
$0.00 |
$-26.28M |
- |
| 2020 |
$-9.30 |
$0.00 |
$-55.24M |
- |
| 2021 |
$-11.01 |
$0.00 |
$-65.35M |
- |
| 2022 |
$-6.80 |
$0.00 |
$-41.82M |
- |
| 2023 |
$-7.58 |
$0.00 |
$-51.21M |
- |
| 2024 |
$-18.94 |
$0.00 |
$-25.43M |
- |
| 2025 |
$-10.41 |
$0.00 |
$0.00 |
- |
